Login / Signup

Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis.

Mahesh Anantha NarayananKeith LoveSameer NagpalAzfar Bilal SheikhChristopher J ReganCarlos Mena-Hurtado
Published in: Expert review of medical devices (2020)
Currently available data supports the use of DCBs as a first-line therapy in patients with FP ISR, with lower rates of TLR and higher patency rates at 1-year follow-up, when compared to POBA. Further randomized studies are essential to evaluate longer term safety and efficacy of DCBs.
Keyphrases